Eurofins Scientific SE/ FR0014000MR3 /
| 2024-11-12 5:28:37 PM | Chg. -1.23 | Volume | Bid2024-10-17 | Ask2024-09-20 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 45.48EUR | -2.63% | 619 Turnover: 28,241.40 |
-Bid Size: - | -Ask Size: - | 8.76 bill.EUR | 1.10% | 15.34 |
Assets
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 137.1000 | 163.2000 | 209.3000 | 251.1000 | 323.7000 | ||||||
| Intangible Assets | 30.2000 | 59.2000 | 69 | 86.4000 | 193.5000 | ||||||
| Long-Term Investments | 6.8000 | 7.9000 | 11 | 16.8000 | 23.3000 | ||||||
| Fixed Assets | - | - | - | - | - | ||||||
| Inventories | 8.4000 | 10 | 13.9000 | 20.1000 | 24.6000 | ||||||
| Accounts Receivable | 154 | 214.8000 | 247.9000 | 272.7000 | 321.5000 | ||||||
| Cash and Cash Equivalents | 107.5000 | 179.5000 | 134.3000 | 297.3000 | 216.6000 | ||||||
| Current Assets | 295.8000 | 441.9000 | 433.2000 | 644.5000 | 621.1000 | ||||||
| Total Assets | 736.2000 | 1,074.6000 | 1,159.1000 | 1,497 | 1,873.2000 | ||||||
Liabilities
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 54.9000 | 75 | 77.8000 | 101 | 127.1000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 21.9000 | 19.2000 | 37.2000 | 31.3000 | 96 | ||||||
| Provisions | 11.3000 | 20.9000 | 25.4000 | 29 | 42.3000 | ||||||
| Liabilities | 505.4000 | 754.3000 | 783 | 1,102.3000 | 1,208.9000 | ||||||
| Share Capital | 1.4000 | 1.4000 | 1.5000 | 1.5000 | 1.5200 | ||||||
| Total Equity | 225 | 315.5000 | 374.6000 | 387.7000 | 656.5000 | ||||||
| Minority Interests | 5.7000 | 4.9000 | 1.5000 | 7.1000 | 7.8000 | ||||||
| Total liabilities equity | 736.2000 | 1,074.6000 | 1,159.1000 | 1,497 | 1,873.2000 | ||||||
Income Statement
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 680.3000 | 828.9000 | 1,044 | 1,225.6000 | 1,410.2000 | ||||||
| Depreciation (total) | 41.1000 | 45.9000 | 54.8000 | 66.9000 | 81.3000 | ||||||
| Operating Result | 48.7000 | 86.5000 | 101.2000 | 112.2000 | 131.8000 | ||||||
| Interest Income | -12.7000 | -16.4000 | -19.7000 | -23.5000 | -30.8000 | ||||||
| Income Before Taxes | 36.2000 | 70.4000 | 81.7000 | 89.1000 | 100.8000 | ||||||
| Income Taxes | 10.8000 | 13.8000 | 17.8000 | 17.2000 | 22.2000 | ||||||
| Minority Interests Profit | -1.9000 | -1.2000 | 2 | .3000 | -.0300 | ||||||
| Net Income | 23.4000 | 55.4000 | 65.9000 | 72.2000 | 79.1000 | ||||||
Per Share
Cash Flow
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 84.9000 | 110.3000 | 134.2000 | 169.3000 | 212.2000 | ||||||
| Cash Flow from Investing Activities | -48.3000 | -204.2000 | -144.4000 | -189 | -422.4000 | ||||||
| Cash Flow from Financing | 6.1000 | 170.7000 | -40.5000 | 194 | 129.8000 | ||||||
| Decrease / Increase in Cash | 44.1000 | 77.4000 | -51.5000 | 171.1000 | -78.2000 | ||||||
| Employees | 7,222 | 8,742 | 10,890 | 12,933 | 14,855 | ||||||
